200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 113494-48-7

113494-48-7

113494-48-7 | 2,4-Pyrimidinediamine, 5-[4-chloro-3-(3,3-dimethyl-1-triazen-1-yl)phenyl]-6-ethyl-

CAS No: 113494-48-7 Catalog No: AG0008RS MDL No:

Product Description

Catalog Number:
AG0008RS
Chemical Name:
2,4-Pyrimidinediamine, 5-[4-chloro-3-(3,3-dimethyl-1-triazen-1-yl)phenyl]-6-ethyl-
CAS Number:
113494-48-7
Molecular Formula:
C14H18ClN7
Molecular Weight:
319.7926
IUPAC Name:
5-[4-chloro-3-(dimethylaminodiazenyl)phenyl]-6-ethylpyrimidine-2,4-diamine
InChI:
InChI=1S/C14H18ClN7/c1-4-10-12(13(16)19-14(17)18-10)8-5-6-9(15)11(7-8)20-21-22(2)3/h5-7H,4H2,1-3H3,(H4,16,17,18,19)
InChI Key:
WFFVOYIYKQPAFS-UHFFFAOYSA-N
SMILES:
CCc1nc(N)nc(c1c1ccc(c(c1)N=NN(C)C)Cl)N
NSC Number:
330465

Properties

Complexity:
378  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
319.131g/mol
Formal Charge:
0
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
319.797g/mol
Monoisotopic Mass:
319.131g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
106A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.1  

Literature

Title Journal
Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS. Journal of medicinal chemistry 20030424
Structural studies on bioactive compounds. 34. Design, synthesis, and biological evaluation of triazenyl-substituted pyrimethamine inhibitors of Pneumocystis carinii dihydrofolate reductase. Journal of medicinal chemistry 20010802
Structural studies on bioactive compounds. 28. Selective activity of triazenyl-substituted pyrimethamine derivatives against Pneumocystis carinii dihydrofolate reductase. Journal of medicinal chemistry 19970606
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii. Journal of medicinal chemistry 19951124
Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii. Antimicrobial agents and chemotherapy 19951101
Identification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductase. Antimicrobial agents and chemotherapy 19930901
Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs. Antimicrobial agents and chemotherapy 19910701
Inhibition of Pneumocystis dihydrofolate reductase by analogs of pyrimethamine, methotrexate and trimetrexate. The Journal of protozoology 19910101

Related Products

© 2019 Angene International Limited. All rights Reserved.